Virogin Biotech Employee Directory
Biotechnology ResearchBritish Columbia, Canada11-50 Employees
Virogin Biotech is a biotechnology research company based in Richmond, British Columbia, that focuses on developing cancer therapies based on oncolytic viruses. Its platform aims to elicit durable antitumor immunity by coordinating a transient antiviral response with multiple payloads, with the goal of boosting systemic immune activity against relapsed or refractory cancers. The leadership team brings more than 25 years of combined experience in immunotherapy and oncolytic virotherapy. Its pipeline comprises two complementary approaches: a therapeutic virus platform designed to improve oncolysis and modulate the tumor microenvironment, and a discovery-stage mRNA tumor vaccine program intended for use alongside oncolytic viruses. The lead candidate VG161 has advanced in clinical development after an FDA IND granted, enabling a Phase II trial. The company has pursued international expansion to support its R&D efforts, including establishing facilities in Shanghai.